Trial Outcomes & Findings for Intrapulmonary Percussive Ventilation for Sputum Induction in Adults With Cystic Fibrosis (NCT NCT06311292)

NCT ID: NCT06311292

Last Updated: 2026-04-29

Results Overview

Percentage of patients with a successful culture result from sputum

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

20 participants

Primary outcome timeframe

10 minutes

Results posted on

2026-04-29

Participant Flow

Participant milestones

Participant milestones
Measure
Intrapulmonary Percussive Ventilation for Non-sputum Producer
Unable to produce adequate amount of lower airway bacterial sampling for culture results in last year. Volara System: Intrapulmonary percussive ventilation for mobilizing mucus.
Overall Study
STARTED
20
Overall Study
COMPLETED
20
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Intrapulmonary Percussive Ventilation for Non-sputum Producer
n=20 Participants
Unable to produce adequate amount of lower airway bacterial sampling for culture results in last year. Volara System: Intrapulmonary percussive ventilation for mobilizing mucus.
Age, Categorical
<=18 years
0 Participants
n=20 Participants
Age, Categorical
Between 18 and 65 years
20 Participants
n=20 Participants
Age, Categorical
>=65 years
0 Participants
n=20 Participants
Age, Continuous
20 years
n=20 Participants
Sex: Female, Male
Female
7 Participants
n=20 Participants
Sex: Female, Male
Male
13 Participants
n=20 Participants
Region of Enrollment
United States
20 participants
n=20 Participants

PRIMARY outcome

Timeframe: 10 minutes

Percentage of patients with a successful culture result from sputum

Outcome measures

Outcome measures
Measure
Intrapulmonary Percussive Ventilation for Non-sputum Producer
n=20 Participants
Unable to produce adequate amount of lower airway bacterial sampling for culture results in last year. Volara System: Intrapulmonary percussive ventilation for mobilizing mucus.
Sufficient Sputum Quantity for a Pellet
9 Participants

Adverse Events

Intrapulmonary Percussive Ventilation for Non-sputum Producer

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Daniel Weiner

UPMC Children's Hospital of Pittsburgh

Phone: 412-692-5630

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place